Small Business Innovation Research · Small Business Technology Transfer
Sanaria Inc.: SBIR & STTR awards
61 awards worth $99.33M to 1 companies since 2003 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
Sanaria Inc.'s federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2024 | 0 | 1 | $2.00M |
| 2023 | 2 | 2 | $7.15M |
| 2022 | 2 | 2 | $4.82M |
| 2021 | 1 | 2 | $6.52M |
| 2020 | 2 | 4 | $12.95M |
| 2019 | 1 | 0 | $593.4K |
| 2018 | 2 | 2 | $5.16M |
| 2017 | 1 | 2 | $6.06M |
| 2016 | 2 | 3 | $11.42M |
| 2015 | 1 | 2 | $6.61M |
| 2014 | 1 | 1 | $3.08M |
| 2013 | 2 | 2 | $7.20M |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
By agency
- Department of Health and Human Services 59 awards · $98.18M
- Department of Defense 2 awards · $1.15M
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.00M | 2024-08-01 |
| Modularizing manufacture of PfSPZ vaccines: ookinete production for PfSPZ manufacture in mosquitoes and in vitro · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $559.9K | 2023-09-06 |
| Progressing PfSPZ vaccines for malaria to licensure and commercialization · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.99M | 2023-04-14 |
| A genetically modified Plasmodium falciparum sporozoite vaccine attenuated at the late-liver stage · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $3.00M | 2023-04-01 |
| Conditional male lethal Anopheles stephensi line for the efficient manufacture of malaria vaccines · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $600.0K | 2023-02-14 |
| PfSPZ Vaccine for Prevention of Plasmodium falciparum malaria · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $988.8K | 2022-09-01 |
| A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.94M | 2022-07-05 |
| In vitro bioreactor production of a genetically modified late liver stage-arresting replication competent Plasmodium falciparum sporozoite vaccine · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $600.0K | 2022-06-03 |
| Development of monoclonal antibody-mediated interventions to combat malaria · topic 109 | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $298.6K | 2022 |
| Automating mosquito microdissection for a malaria PfSPZ vaccine · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.92M | 2021-05-01 |
| A Unique Automated Bioreactor for Rearing Aseptic Mosquitoes from Larvae to Adults to Support Manufacture of Sanaria PfSPZ Products · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $3.00M | 2021-04-15 |
| Attenuation of Liquid Formulation for PfSPZ Vaccine by X-Ray · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $600.0K | 2021-04-12 |
| Enhancement of gametocytogenesis in Plasmodium falciparum by genetic engineering for improved PfSPZ Vaccine Manufacture · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $600.0K | 2020-08-17 |
| PfSPZ Vaccine for Malaria: Towards a Successful Biologics License Application and Commercialization · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.97M | 2020-07-08 |
| In-Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.91M | 2020-06-15 |
| Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.94M | 2020-06-01 |
| A genetically modified Plasmodium falciparum sporozoite vaccine attenuated at the late-liver stage. · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $600.0K | 2020-04-21 |
| Cryopreservation of Anopheles Embryos · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.93M | 2020-02-18 |
| Genetically Modified Conditional Sexing A. stephensi Line for PfSPZ Manufacture · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $593.4K | 2019-03-07 |
| A Unique Automated Bioreactor for Rearing Aseptic Mosquitoes from Larvae to Adults to Support Manufacture of Sanaria PfSPZ Products. · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $600.0K | 2018-07-18 |
| Delivery System for Cryopreserved Eukaryotic Cell Vaccines · topic DHP163-003 | Sanaria Inc. · Maryland | Department of Defense · Defense Health Agency | SBIR Phase II | $1000.0K | 2018-05-21 |
| Development, GMP manufacture, and quality control release of a triple knock out genetically attenuated Plasmodium falciparum sporozoite vaccine · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $600.0K | 2018-03-08 |
| Automating mosquito microdissection for a malaria PfSPZ vaccine · topic R | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.96M | 2017-06-20 |
| Immune Deficient Mosquitoes for Improved Malaria Sporozoite Vaccine Manufacture · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.95M | 2017-08-02 |
| Marketing Strategic Plan and Distribution Logistics for Sanaria PfSPZ Vaccine against Malaria. · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.96M | 2017-05-01 |
| Delivery System for Cryopreserved Eukaryotic Cell Vaccines · topic DHP163-003 | Sanaria Inc. · Maryland | Department of Defense · Defense Health Agency | SBIR Phase I | $150.0K | 2017-04-24 |
| PfSPZ Vaccines: Quality Systems, Manufacturing, Regulatory, and Clinical Quality and Data Management Support for Product Commercialization · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.94M | 2016-08-01 |
| PfSPZ Vaccines Quality Systems Manufacturing Regulatory and Clinical Quality and Data Management Support for Product Commercialization · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $1.97M | 2016-08-01 |
| A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with a live attenuated sporozoite malaria vaccine · topic R | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $3.00M | 2016-06-16 |
| Universal Attenuated Sporozoite Vaccine and Challenge System · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.91M | 2016-06-15 |
| Manufacture of aseptic purified cryopreserved Plasmodium vivax sporozoites PvSPZ Challenge for controlled human malaria infection CHMI · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $600.0K | 2016-04-21 |
| Development of a whole parasite Plasmodium falciparum sexual and mosquito stages Vaccine to Interrupt Malaria Transmission · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $613.4K | 2015-02-18 |
| In Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine · topic R | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $3.00M | 2015-01-01 |
| Genetically Attenuated PfSPZ Malaria Vaccine · topic R | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $3.00M | 2015-01-01 |
| Cryopreservation of Anopheles Embryos · topic R | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.48M | 2014-08-25 |
| Automating mosquito microdissection for a malaria PfSPZ vaccine · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $600.0K | 2014-02-15 |
| Plasmodium Falciparum Whole Sporozoite Malaria Vaccine · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $3.00M | 2013-08-06 |
| Plasmodium Falciparum Whole Sporozoite Malaria Vaccine · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $3.00M | 2013 |
| Micro_patterned Surfaces for Reducing the Risk of Ventilator_Associated Pneumonia · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $600.0K | 2013 |
| Mentoring Central: Mobile and Web Training for Mentees and their Caregivers · topic NIAID | Sanaria Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $597.7K | 2013 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.